IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

European Oncology and Haematology

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on October 31, 2023

Impact Score

2022-2023

0.43

h-Index

2022-2023

 8

Rank

2022-2023

 24220

SJR

2022-2023

 0.120

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title European Oncology and Haematology
Abbreviation Eur. Oncol. Haematol.
Publication Type Journal
Subject Area, Categories, Scope Hematology (Q4); Oncology (Q4)
h-index 8
Overall Rank/Ranking 24220
SCImago Journal Rank (SJR) 0.120
Impact Score 0.43
Publisher Touch Digital Media
Country United Kingdom
ISSN 20455275, 20455283
Best Quartile Q4
Coverage History 2012-2020




About European Oncology and Haematology


European Oncology and Haematology is a journal covering the technologies/fields/categories related to Hematology (Q4); Oncology (Q4). It is published by Touch Digital Media. The overall rank of European Oncology and Haematology is 24220. According to SCImago Journal Rank (SJR), this journal is ranked 0.120. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 8. The best quartile for this journal is Q4.

The ISSN of European Oncology and Haematology journal is 20455275, 20455283. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. European Oncology and Haematology is cited by a total of 4 articles during the last 3 years (Preceding 2022).


European Oncology and Haematology Impact IF 2022-2023


The Impact IF 2022 of European Oncology and Haematology is 0.43, which is computed in 2023 as per its definition. European Oncology and Haematology IF is increased by a factor of 0.35 and approximate percentage change is 437.5% when compared to preceding year 2021, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

European Oncology and Haematology Impact IF 2023 Prediction


Impact IF 2022 of European Oncology and Haematology is 0.43. If the same upward trend persists, Impact IF may rise in 2023 as well.


Impact IF Trend


Year wise Impact IF of European Oncology and Haematology. Based on Scopus data.


Year Impact IF
2023/2024 Coming Soon
2022 0.43
2021 0.08
2020 0.14
2019 0.23
2018 0.14
2017 0.16
2016 0.19
2015 0.14
2014 0.10

European Oncology and Haematology h-index


  Table Setting

European Oncology and Haematology has an h-index of 8. It means 8 articles of this journal have more than 8 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




European Oncology and Haematology ISSN


The ISSN of European Oncology and Haematology is 20455275, 20455283. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

European Oncology and Haematology Rank and SCImago Journal Rank (SJR)


The overall rank of European Oncology and Haematology is 24220. According to SCImago Journal Rank (SJR), this journal is ranked 0.120. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of European Oncology and Haematology by Year


Year SJR
2023/2024 Coming Soon
2022 0.120
2021 0.134
2020 0.116
2019 0.139
2018 0.136
2017 0.137
2016 0.127
2015 0.139
2014 0.107

Ranking of European Oncology and Haematology by Year


Year Ranking
2023/2024 Coming Soon
2022 24220
2021 22154
2020 27539
2019 22626
2018 22831
2017 22470
2016 23913
2015 22107
2014 26919

European Oncology and Haematology Publisher


Table Setting

European Oncology and Haematology is published by Touch Digital Media. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2012-2020. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of European Oncology and Haematology is Eur. Oncol. Haematol.. This abbreviation ('Eur. Oncol. Haematol.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in European Oncology and Haematology


If your research field is/are related to Hematology (Q4); Oncology (Q4), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the European Oncology and Haematology?

European Oncology and Haematology latest impact IF is 0.43. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 0.43 (2022) and 0.08 (2021), respectively, in the last 9 years. Moreover, its average IS is 0.18 in the previous 9 years.


What's the SCImago Journal Rank (SJR) of the European Oncology and Haematology?

The European Oncology and Haematology has an SJR (SCImago Journal Rank) of 0.120, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 0.139 in 2019 and the lowest being 0.107 in 2014. Furthermore, the average SJR of the European Oncology and Haematology over the previous 9-year period stands at 0.18.


What's the latest h-index of the European Oncology and Haematology?

The latest h-index of the European Oncology and Haematology is 8.


Who's the publisher of the European Oncology and Haematology?

The European Oncology and Haematology is published by the Touch Digital Media, with its country of publication being the United Kingdom.


What's the current ranking of the European Oncology and Haematology?

The European Oncology and Haematology is currently ranked 24220 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 22107 in 2015 and its lowest position of 27539 in 2020.


What's the abbreviation or short name for the European Oncology and Haematology?

The standard ISO4 abbreviation for the European Oncology and Haematology is Eur. Oncol. Haematol..


Is the "European Oncology and Haematology" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

European Oncology and Haematology is classified as a journal that the Touch Digital Media publishes.


What's the scope or major areas of the European Oncology and Haematology?

The European Oncology and Haematology encompasses the following areas:

  • Hematology
  • Oncology

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the European Oncology and Haematology?

The European Oncology and Haematology is assigned the following International Standard Serial Numbers (ISSN): 20455275, 20455283.


What's the best quartile of the European Oncology and Haematology?

The best quartile for the European Oncology and Haematology is Q4 (2022).


What's the coverage history of the European Oncology and Haematology?

The European Oncology and Haematology coverage history can be summarized as follows: 2012-2020.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Business Strategy Review journal 31512 Wiley-Blackwell Publishing Ltd 33 0.04
Acta Periodica Technologica journal 19470 University of Novi Sad, Faculty of Technology 18 0.62
Canadian Journal of Mathematics journal 3905 Canadian Mathematical Society 43 0.79
Psycho-Oncologie journal 24009 Springer Paris 11 0.13
Expert Review of Obstetrics and Gynecology journal 17060 Expert Reviews Ltd. 21 0.00
Economics of Innovation and New Technology journal 6153 Routledge 62 3.55
Dynamics of Partial Differential Equations journal 5760 International Press of Boston, Inc. 22 1.36
Brazilian Journal of Physical Therapy journal 4378 Elsevier Editora Ltda 45 3.41
Epites-Epiteszettudomany journal 23580 Akademiai Kiado 4 0.06
Biomarker Insights journal 5159 Libertas Academica Ltd. 38 3.46

Check complete list




Year wise Impact Score (IS) of European Oncology and Haematology

Impact Score Table

Year Impact Score (IS)
2023/2024 Coming Soon
2022 0.43
2021 0.08
2020 0.14
2019 0.23
2018 0.14
2017 0.16
2016 0.19
2015 0.14
2014 0.10



Top Journals/Conferences in Hematology

Ca-A Cancer Journal for Clinicians
Wiley-Blackwell | United States

Annals of Oncology
Elsevier Ltd. | United Kingdom

Journal of Hematology and Oncology
BioMed Central Ltd. | United Kingdom

Blood
Elsevier BV | United States

Lancet Haematology,The
Lancet Publishing Group | United Kingdom

Blood Cancer Journal
Nature Publishing Group | United States

Leukemia
Nature Publishing Group | United Kingdom

Journal of Thrombosis and Haemostasis
Wiley-Blackwell Publishing Ltd | United Kingdom

Blood advances
Elsevier BV | United States

American Journal of Hematology
Wiley-Liss Inc. | United States

See All

Top Journals/Conferences in Oncology

Ca-A Cancer Journal for Clinicians
Wiley-Blackwell | United States

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Nature Reviews Clinical Oncology
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Lancet Oncology, The
Elsevier Ltd. | United Kingdom

Annals of Oncology
Elsevier Ltd. | United Kingdom

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Nature Cancer
| United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

JAMA Oncology
American Medical Association | United States

See All